Long-Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group.

Sokol E, Naranjo A, Chen L, Mody R, DuBois SG, Bagatell R, Pinto N

Open source

DOI
10.1002/1545-5017.70504
Published
2026 Sep
Container
Pediatric blood & cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/1545-5017.70504,
  title = {Long-Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group.},
  author = {Sokol E and Naranjo A and Chen L and Mody R and DuBois SG and Bagatell R and Pinto N},
  year = {2026},
  journal = {Pediatric blood \& cancer},
  doi = {10.1002/1545-5017.70504},
  url = {https://doi.org/10.1002/1545-5017.70504}
}

RIS

TY  - JOUR
TI  - Long-Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group.
AU  - Sokol E
AU  - Naranjo A
AU  - Chen L
AU  - Mody R
AU  - DuBois SG
AU  - Bagatell R
AU  - Pinto N
PY  - 2026
JO  - Pediatric blood & cancer
DO  - 10.1002/1545-5017.70504
UR  - https://doi.org/10.1002/1545-5017.70504
ER  - 

APA

E, S., A, N., L, C., R, M., SG, D., R, B., & N, P. (2026). Long-Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group.. Pediatric blood & cancer. https://doi.org/10.1002/1545-5017.70504

Source records